G2-phase chromosomal radiosensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls
- PMID: 20041760
- PMCID: PMC2819004
- DOI: 10.1667/RR1943.1
G2-phase chromosomal radiosensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls
Abstract
We previously described an enhanced sensitivity for cell killing and gamma-H2AX focus induction after both high-dose-rate and continuous low-dose-rate gamma irradiation in 14 primary fibroblast strains derived from hereditary-type retinoblastoma family members (both affected RB1(+/-) probands and unaffected RB1(+/+) parents). Here we present G(2)-phase chromosomal radiosensitivity assay data for primary fibroblasts derived from these RB family members and five Coriell cell bank controls (four apparently normal individuals and one bilateral RB patient). The RB family members and two normal Coriell strains had significantly higher ( approximately 1.5-fold, P < 0.05) chromatid-type aberration frequencies in the first postirradiation mitosis after doses of 50 cGy and 1 Gy of (137)Cs gamma radiation compared to the remaining Coriell strains. The induction of chromatid-type aberrations by high-dose-rate G(2)-phase gamma irradiation is significantly correlated to the proliferative ability of these cells exposed to continuous low-dose-rate gamma irradiation (reported in Wilson et al., Radiat. Res. 169, 483-494, 2008). Our results suggest that these moderately radiosensitive individuals may harbor hypomorphic genetic variants in genomic maintenance and/or DNA repair genes or may carry epigenetic changes involving genes that more broadly modulate such systems, including G(2)-phase-specific DNA damage responses.
Figures


Similar articles
-
Radiation sensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls: colony formation ability during continuous low-dose-rate gamma irradiation.Radiat Res. 2008 May;169(5):483-94. doi: 10.1667/RR1333.1. Radiat Res. 2008. PMID: 18439048
-
Cytogenetic responses to G2 phase x-irradiation of cells from retinoblastoma patients.Cancer Genet Cytogenet. 1996 May;88(1):43-8. doi: 10.1016/0165-4608(95)00279-0. Cancer Genet Cytogenet. 1996. PMID: 8630978
-
G2 radiosensitivity of cells derived from cancer-prone individuals.Mutat Res. 1995 Apr;328(1):83-90. doi: 10.1016/0027-5107(95)00002-z. Mutat Res. 1995. PMID: 7898507
-
G2 chromatid damage and repair kinetics in normal human fibroblast cells exposed to low- or high-LET radiation.Cytogenet Genome Res. 2004;104(1-4):211-5. doi: 10.1159/000077491. Cytogenet Genome Res. 2004. PMID: 15162040 Review.
-
G2 chromatid aberrations: kinetics and possible mechanisms.Environ Mol Mutagen. 1993;22(4):250-6. doi: 10.1002/em.2850220412. Environ Mol Mutagen. 1993. PMID: 8223506 Review.
Cited by
-
Variation in base excision repair capacity.Mutat Res. 2011 Jun 3;711(1-2):100-12. doi: 10.1016/j.mrfmmm.2010.12.004. Epub 2010 Dec 15. Mutat Res. 2011. PMID: 21167187 Free PMC article. Review.
-
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists.Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):698-712. doi: 10.1016/j.ijrobp.2019.07.026. Epub 2019 Aug 2. Int J Radiat Oncol Biol Phys. 2019. PMID: 31381960 Free PMC article. Review.
-
Epidemiology and Rb1 gene of retinoblastoma.Int J Ophthalmol. 2011;4(1):103-9. doi: 10.3980/j.issn.2222-3959.2011.01.24. Epub 2011 Feb 18. Int J Ophthalmol. 2011. PMID: 22553621 Free PMC article.
-
Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy.Cancer Drug Resist. 2021;4(2):244-263. doi: 10.20517/cdr.2020.89. Epub 2021 Jun 19. Cancer Drug Resist. 2021. PMID: 34337349 Free PMC article.
-
Influence of homologous recombinational repair on cell survival and chromosomal aberration induction during the cell cycle in gamma-irradiated CHO cells.DNA Repair (Amst). 2010 Jul 1;9(7):737-44. doi: 10.1016/j.dnarep.2010.03.009. DNA Repair (Amst). 2010. PMID: 20434408 Free PMC article.
References
-
- Wilson PF, Nagasawa H, Warner CL, Fitzek MM, Little JB, Bedford JS. Radiation sensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls: colony formation ability during continuous low-dose-rate gamma irradiation. Radiat Res. 2008;169:483–494. - PubMed
-
- Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92:874–897. - PubMed
-
- Mohrenweiser HW, Wilson DM, 3rd, Jones IM. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res. 2003;526:93–125. - PubMed
-
- Chistiakov DA, Voronova NV, Chistiakov PA. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol. 2008;47:809–824. - PubMed
-
- Bhatti P, Struewing JP, Alexander BH, Hauptmann M, Bowen L, Mateus-Pereira LH, Pineda MA, Simon SL, Weinstock RM, Sigurdson AJ. Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. radiologic technologists. Int J Cancer. 2008;122:177–182. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous